(NVKP-16-1-2016-0017 National Heart Program) Támogató: NKFIH
(OTKA K120237)
(VEKOP-2.3.2-16-2016-000002)
(VEKOP-2.3.3-15-2017-00016)
(H2020-MSCA-ITN-2017-722148 TRAIN EV)
(739593) Támogató: Horizon 2020
(TKP2020-NKA-26)
The twenty-first century has witnessed major developments in the field of extracellular
vesicle (EV) research, including significant steps towards defining standard criteria
for the separation and detection of EVs. The recent recognition that EVs have the
potential to function as biomarkers or as therapeutic tools has attracted even greater
attention to their study. With this progress in mind, an updated comprehensive overview
of the roles of EVs in the immune system is timely. This Review summarizes the roles
of EVs in basic processes of innate and adaptive immunity, including inflammation,
antigen presentation, and the development and activation of B cells and T cells. It
also highlights key progress related to deciphering the roles of EVs in antimicrobial
defence and in allergic, autoimmune and antitumour immune responses. It ends with
a focus on the relevance of EVs to immunotherapy and vaccination, drawing attention
to ongoing or recently completed clinical trials that aim to harness the therapeutic
potential of EVs. Extracellular vesicles (EVs) are increasingly recognized as having
ubiquitous roles in the immune system. This Review focuses on the progress made in
the field in the past 5 years, including the roles of EVs in innate and adaptive immunity
and their potential use in diagnosis and therapy.